Loxo-Bayer cancer drug gets priority review from FDA - Nano News Online

Tuesday, May 29, 2018

Loxo-Bayer cancer drug gets priority review from FDA

(Reuters) - Loxo Oncology and Bayer AG said on Tuesday the U.S. Food and Drug Administration granted priority review to their cancer drug and would decide on the marketing application by Nov. 26.


from Reuters: Health News https://ift.tt/2LCpUa6

No comments:

Post a Comment